Item 1A. Risk Factors

There have been no material changes in our risk factors disclosed in Part 1, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended June 30, 2024.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Issuer Purchases of Equity Securities


	Total Number of Shares Purchased (1)	Average Price Paid per Share (3)		Total Number of Shares Purchased as Part of the Publicly Announced Common Stock Repurchase Plan (2)	Maximum Approximate Dollar Value of Shares that may yet be Purchased under the Common Stock Repurchase Plan (2) (3)
Period
October 1 to 31, 2024	298,902	$	288.95	298,829	$	2,619,779,352

November 1 to 30, 2024	291,632	$	303.82	290,708	$	2,531,459,636

December 1 to 31, 2024	336,248	$	300.00	332,671	$	2,431,630,798
Total	926,782			922,208


(1)						During the three months ended December 31, 2024, pursuant to the terms of the Company’s restricted stock program, the Company purchased 4,574 shares at the then-market value of the shares to satisfy certain tax withholding requirements for employees upon the vesting of their restricted shares.

(2)						The Company received the Board of Directors' approval in November 2022 to repurchase $5 billion of its common stock.

(3)						Inclusive of the impact of the one-percent excise tax under the Inflation Reduction Act of 2022.

There is no expiration date for the common stock repurchase authorization.

Previous: Item 4. Controls and Procedures · Next: Item 5. Other Information